Ligand validation:5VJM

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5VJM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VJM_NAG_A_501	37%	68%	0.153	0.851	0.68	0.56	-	-	0	0	100%	0.9333
5VJM_NAG_A_502	34%	5%	0.185	0.87	2.55	2.91	2	2	1	0	100%	0.9333
5VJM_NAG_B_201	23%	41%	0.248	0.87	1.22	1.06	2	1	3	0	100%	0.9333
4LN3_NAG_K_800	100%	41%	0.04	0.989	0.44	1.83	-	3	0	0	100%	0.9333
4LN8_NAG_F_500	98%	17%	0.056	0.975	1	2.58	1	7	1	0	100%	0.9333
4KOL_NAG_B_501	84%	79%	0.098	0.959	0.29	0.56	-	-	1	0	100%	0.9333
4LKJ_NAG_B_501	77%	68%	0.112	0.951	0.51	0.73	-	-	1	0	100%	0.9333
6IDZ_NAG_B_201	72%	80%	0.114	0.936	0.31	0.52	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.